Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to US Adults With Heart Failure

被引：4
|
作者：
Ostrominski, John W. [1 ,2 ,3 ]
Aggarwal, Rahul [1 ,2 ]
Claggett, Brian L. [1 ,2 ]
Kulac, Ian J. [1 ,2 ]
Desai, Akshay S. [1 ,2 ]
Jhund, Pardeep S. [4 ]
Lam, Carolyn S. P. [5 ]
Pitt, Bertram [6 ]
Senni, Michele [7 ,8 ]
Shah, Sanjiv J. [9 ]
Voors, Adriaan A. [10 ]
Zannad, Faiez [11 ]
Lay-Flurrie, James [12 ]
Viswanathan, Prabhakar [13 ]
McMurray, John J. V. [4 ]
Solomon, Scott D. [1 ,2 ]
Vaduganathan, Muthiah [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Cardiovasc Div, Cardiovasc Div, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Div Endocrinol Diabet & Hypertens, Boston, MA USA
[4] Univ Glasgow, Sch Cardiovasc & Metab Hlth, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Scotland
[5] Duke Natl Univ Singapore, Natl Heart Ctr Singapore, Singapore, Singapore
[6] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI USA
[7] Univ Bicocca Milan, Milan, Italy
[8] Papa Giovanni XXIII Hosp, Bergamo, Italy
[9] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[10] Univ Groningen, Groningen, Netherlands
[11] Univ Lorraine, CHU, Inserm, Clin Invest Ctr, Nancy, France
[12] Bayer Pharmaceut, Res & Dev, Preclin Res, Wuppertal, Germany
[13] Bayer Res & Dev, Pharmaceut, Whippany, NJ USA
来源：
JOURNAL OF CARDIAC FAILURE | 2024年 / 30卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2024.04.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1170 / 1174
页数：5
相关论文
共 50 条
  • [21] Efficacy and safety of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified sex-specific analysis of the FINEARTS-HF trial
    Chimura, Misato
    Jhund, Pardeep
    Henderson, Alasdair David
    Claggett, Brian
    Desai, Akshay
    Mueller, Katharina
    Glasauer, Andrea
    Rohwedder, Katja
    Viswanathan, Prabhakar
    Lam, Carolyn
    Senni, Michele
    Shah, Sanjiv
    Voors, Adriaan
    Zannad, Faiez
    Pitt, Bertram
    Vaduganathan, Muthiah
    Solomon, Scott
    McMurray, John
    CIRCULATION, 2024, 150 (25) : E735 - E736
  • [22] Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF
    Chimura, Misato
    Petrie, Mark C.
    Schou, Morten
    Martinez, Felipe A.
    Henderson, Alasdair D.
    Claggett, Brian L.
    Desai, Akshay S.
    Kolkhof, Peter
    Viswanathan, Prabhakar
    Lage, Andrea
    Lam, Carolyn S. P.
    Senni, Michele
    Shah, Sanjiv J.
    Rohwedder, Katja
    Mueller, Katharina
    Voors, Adriaan A.
    Zannad, Faiez
    Pitt, Bertram
    Vaduganathan, Muthiah
    Jhund, Pardeep S.
    Solomon, Scott D.
    Mcmurray, John J. V.
    CIRCULATION-HEART FAILURE, 2024, 17 (11)
  • [23] A gamified behavioral science intervention to enhance trial enrollment: an embedded study within the FINEARTS-HF trial
    Bhatt, A. Ankeet
    Chatur, S.
    Claggett, B.
    Barytol, A.
    Lay-Flurrie, J.
    Viswanathan, P.
    Vardeny, O.
    Kosiborod, M.
    Sharma, K.
    Solomon, S.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 431 - 432
  • [24] Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fraction
    Volpe, Massimo
    Galiuto, Leonarda
    EUROPEAN HEART JOURNAL, 2024, 46 (01) : 103 - 104
  • [25] Lifetime risk of kidney failure among US adults with diabetes
    Obi, Y.
    Zhu, X.
    Tio, M.
    Yen, T.
    Hall, M. E.
    Dossabhoy, N.
    Shafi, T.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S467 - S468
  • [26] Generalizability of the US FDA Label for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in the GWTG-HF Registry
    Vaduganathan, Muthiah
    Greene, Stephen
    Zhang, Shuaiqi
    Grau-Sepulveda, Maria V.
    Devore, Adam D.
    Butler, Javed
    Heidenreich, Paul A.
    Huang, Joanna C.
    Kittleson, Michelle M.
    Maddox, Karen E. Joynt
    McDermott, Jim
    Owens, Anjali T.
    Peterson, Pamela
    Solomon, Scott D.
    Vardeny, Orly
    Yancy, Clyde W.
    Fonarow, Gregg C.
    CIRCULATION, 2020, 142
  • [27] CKD Awareness Among US Adults by Future Risk of Kidney Failure
    Chu, Chi D.
    McCulloch, Charles E.
    Banerjee, Tanushree
    Pavkov, Meda E.
    Burrows, Nilka R.
    Gillespie, Brenda W.
    Saran, Rajiv
    Shlipak, Michael G.
    Powe, Neil R.
    Tuot, Delphine S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (02) : 174 - 183
  • [28] Generalizability Of The Paradigm-HF Trial For The Use Of Sacubitril/Valsartan In A Tertiary Care Outpatient Heart Failure Patient Population
    Sackheim, Julia
    Chan, Doris
    Beers, Kelly
    Khan, Hassan
    Papadimitriou, Lampros
    Bloom, Michelle W.
    Butler, Javed
    Skopicki, Hal
    CIRCULATION, 2016, 134
  • [29] Heart failure -: The trial:: MERIT-HF
    Hjalmarson, A
    CIRCULATION, 1999, 100 (06) : 571 - 571
  • [30] Kidney Measures and Risk of Incident Heart Failure Among Older Adults
    Douros, Antonios
    Schneider, Alice
    Ebert, Natalie
    Fietz, Anne-Katrin
    Huscher, Dorte
    Kuhlmann, Martin K.
    Martus, Peter
    Mielke, Nina
    van der Giet, Markus
    Wenning, Volker
    Schaeffner, Elke
    JACC-HEART FAILURE, 2023, 11 (11) : 1642 - 1644
12345